Ruiwen Zhang Selected Research

Investigational Therapies (Experimental Therapy)

1/2017	Experimental Therapy of Advanced Breast Cancer: Targeting NFAT1-MDM2-p53 Pathway.
1/2013	Experimental therapy for lung cancer: umbilical cord-derived mesenchymal stem cell-mediated interleukin-24 delivery.
1/2011	Experimental therapy of ovarian cancer with synthetic makaluvamine analog: in vitro and in vivo anticancer activity and molecular mechanisms of action.
6/2010	FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer.
6/2009	Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action.
9/2008	Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action.
6/2008	Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides.
6/2007	Experimental therapy for colon cancer: anti-cancer effects of TLR9 agonism, combination with other therapeutic modalities, and dependence upon p53.
11/2006	Experimental therapy of prostate cancer with an immunomodulatory oligonucleotide: effects on tumor growth, apoptosis, proliferation, and potentiation of chemotherapy.
2/2003	Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruiwen Zhang Research Topics

Disease

99	Neoplasms (Cancer) 01/2021 - 01/2002
20	Breast Neoplasms (Breast Cancer) 01/2017 - 05/2003
15	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 02/2003
12	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2012
11	Pancreatic Neoplasms (Pancreatic Cancer) 12/2018 - 09/2006
10	Carcinogenesis 11/2018 - 12/2004
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2017 - 08/2002
6	Glioma (Gliomas) 03/2021 - 03/2004
5	Lung Neoplasms (Lung Cancer) 12/2015 - 06/2006
4	Hepatocellular Carcinoma (Hepatoma) 10/2019 - 09/2008
4	Colonic Neoplasms (Colon Cancer) 06/2007 - 04/2002
3	Inflammation (Inflammations) 10/2021 - 01/2009
3	Neuroblastoma 01/2021 - 12/2020
3	Hypoxia (Hypoxemia) 01/2021 - 02/2005
3	Brain Neoplasms (Brain Tumor) 01/2020 - 03/2014
3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2002
3	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 07/2009
3	Polyploidy 05/2014 - 05/2013
2	Triple Negative Breast Neoplasms 01/2021 - 03/2017
2	Melanoma (Melanoma, Malignant) 01/2020 - 03/2017
2	Retinoblastoma (Glioblastoma, Retinal) 05/2014 - 09/2003
2	Leukemia 09/2013 - 09/2006
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Obesity 10/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Moyamoya Disease (Moya-Moya Disease) 01/2021
1	Genomic Instability 01/2021
1	Aortic Coarctation 01/2021
1	Uveal melanoma 01/2021

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 03/2021 - 02/2003
19	Pharmaceutical PreparationsIBA 01/2020 - 04/2002
14	OligonucleotidesIBA 06/2007 - 01/2002
13	Biological ProductsIBA 09/2018 - 06/2008
11	Antisense OligonucleotidesIBA 09/2006 - 04/2002
10	Gemcitabine FDA Link 10/2018 - 03/2004
9	GinsenosidesIBA 01/2018 - 03/2007
8	Oncogene Proteins (Oncogene Protein)IBA 10/2019 - 02/2005
7	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2016 - 12/2011
7	Antineoplastic Agents (Antineoplastics)IBA 07/2015 - 04/2002
6	Messenger RNA (mRNA)IBA 03/2021 - 09/2005
6	Therapeutic UsesIBA 10/2014 - 04/2002
5	Transcription Factors (Transcription Factor)IBA 05/2016 - 01/2005
5	Carboplatin (JM8)FDA LinkGeneric 07/2009 - 03/2004
5	Irinotecan (Camptosar)FDA LinkGeneric 11/2007 - 01/2002
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2002
4	UbiquitinIBA 05/2018 - 03/2007
4	Proto-Oncogene Proteins c-mdm2IBA 01/2018 - 09/2005
4	7- (benzylamino)- 1,3,4,8- tetrahydropyrrolo(4,3,2- de)quinolin- 8(1H)- oneIBA 01/2017 - 07/2010
4	Biomarkers (Surrogate Marker)IBA 12/2015 - 04/2007
4	iminoquinoneIBA 07/2015 - 07/2010
4	7- (4- fluorobenzylamino)- 1,3,4,8- tetrahydropyrrolo(4,3,2- de)quinolin- 8(1H)- oneIBA 05/2012 - 05/2009
4	Dexamethasone (Maxidex)FDA LinkGeneric 03/2009 - 03/2004
4	Docetaxel (Taxotere)FDA Link 06/2008 - 08/2005
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2020 - 03/2007
3	6- methoxy- 1- (naphthalen- 1- yl)- 9H- pyrido(3,4- b)indoleIBA 01/2020 - 10/2014
3	indoleIBA 12/2018 - 10/2014
3	artemisinin (artemisinine)IBA 01/2017 - 09/2008
3	25-methoxylprotopanaxadiolIBA 08/2015 - 06/2009
3	Cisplatin (Platino)FDA LinkGeneric 03/2015 - 08/2002
3	Hormones (Hormone)IBA 01/2015 - 02/2005
3	N- (4- (2- amino- 3- chloropyridin- 4- yloxy)- 3- fluorophenyl)- 4- ethoxy- 1- (4- fluorophenyl)- 2- oxo- 1,2- dihydropyridine- 3- carboxamideIBA 05/2014 - 05/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2012 - 04/2007
3	Death Domain ReceptorsIBA 01/2012 - 07/2009
3	CaspasesIBA 01/2012 - 05/2009
3	25-hydroxyprotopanaxadiolIBA 01/2011 - 06/2008
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2003 - 01/2002
2	EnzymesIBA 01/2021 - 10/2015
2	Peptides (Polypeptides)IBA 01/2020 - 01/2005
2	Protein Isoforms (Isoforms)IBA 01/2020 - 12/2014
2	MA242IBA 10/2019 - 10/2018
2	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2018 - 03/2014
2	Disulfiram (Antabuse)FDA Link 01/2018 - 03/2014
2	AndrogensIBA 01/2017 - 09/2008
2	artenimol (dihydroartemisinin)IBA 01/2017 - 07/2009
2	Monoclonal AntibodiesIBA 04/2016 - 01/2015
2	AntibodiesIBA 01/2015 - 01/2005
2	Tyrosine Kinase InhibitorsIBA 05/2014 - 05/2013
2	A-Form DNA (A-DNA)IBA 05/2014 - 03/2014
2	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 05/2014 - 01/2014
2	Aurora Kinase BIBA 01/2014 - 05/2013
2	LigandsIBA 07/2013 - 09/2006
2	Small Interfering RNA (siRNA)IBA 05/2013 - 11/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2012 - 01/2005
2	AlkaloidsIBA 01/2011 - 05/2009
2	Toll-Like Receptor 9IBA 06/2007 - 06/2006
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 04/2007 - 07/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2007 - 09/2006
2	Nucleic AcidsIBA 05/2006 - 01/2005
2	E2F Transcription FactorsIBA 11/2005 - 09/2003
1	ResveratrolIBA 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 01/2021
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	CollagenIBA 01/2021

Therapy/Procedure

74	Therapeutics 03/2021 - 01/2002
20	Drug Therapy (Chemotherapy) 06/2017 - 09/2003
10	Investigational Therapies (Experimental Therapy) 01/2017 - 02/2003
7	Radiotherapy 01/2015 - 12/2003
1	Intravenous Administration 10/2021
1	Cardiac Rehabilitation 01/2021